@article {178,
	title = {Clinical and laboratory trial employing carbaryl against the human head-louse, Pediculus humanus capitis (DeGeer)},
	journal = {Clinical and Experimental Dermatology},
	volume = {6},
	year = {1981},
	month = {1981},
	pages = {605 - 612},
	keywords = {animals, carbaryl, child, Clinical Trials, Comparative Study, Drug Resistance, humans, insecticide, Lice Infestations/drug therapy, Ovum, Pediculus, Research Support, Non-U.S. Gov{\textquoteright}t},
	isbn = {0307-6938},
	author = {Maunder,John W.}
}
@article {105,
	title = {What{\textquoteright}s eating you? Pediculus humanus (head louse and body louse)},
	journal = {Cutis},
	volume = {63},
	year = {1999},
	month = {1999},
	pages = {259 - 264},
	abstract = {Head lice remain a common problem worldwide. As resistance to available therapeutic agents can emerge rapidly, there is a need for continued research to find new and better agents. Until better agents are available, clinicians may find that rotational therapy, using different agents, may help to slow the emergence of resistance. Physical modalities, such as mechanical nit and louse removal and occlusive agents to asphyxiate the lice, should not be ignored, especially in light of our limited therapeutic armamentarium. All therapeutic agents are doomed to failure if infestation is allowed to recur. Classmates, playmates, and family members of infested children should be inspected for head lice. Efforts should be directed at fomite control and nit removal. Louse infestation must be addressed as a community-wide problem. Body lice remain important vectors of disease. War, natural disaster, and poverty favor the spread of body lice. As we work to solve these seemingly eternal problems, we must develop better agents to treat infestation and prevent the spread of body lice.},
	keywords = {adult, animals, carbaryl, child, Diagnosis, Differential, Drug Combinations, humans, insecticide, Ivermectin/therapeutic use, Lice Infestations/diagnosis/drug therapy, Lindane/therapeutic use, malathion, Pediculus, Permethrin, Piperonyl Butoxide, Pyrethrum, Research Support, Non-U.S. Gov{\textquoteright}t, Trimethoprim},
	author = {Elston,D. M.}
}
@article {110,
	title = {Treatment of Pediculus humanus var. capitis infestation in Cowlitz County, Washington, with ivermectin and the LiceMeister(R) comb},
	journal = {Pediatric Infectious Disease Journal},
	volume = {17},
	year = {1998},
	month = {1998},
	pages = {923 - 924},
	keywords = {adolescent, adult, animals, child, Child, Preschool, humans, insecticide, Insecticide Resistance, Ivermectin/therapeutic use, Lice Infestations/drug therapy, Pediculus, Permethrin, Pyrethrum, scalp dermatoses, Washington},
	author = {Bell,T. A.}
}
@article {79,
	title = {Prevalence and treatment of Pediculus humanus capitis with 1\% permethrin and 0.4\% d-phenothrin in Turkey},
	journal = {Acta Medica (Hradec Kralove)},
	volume = {46},
	year = {2003},
	note = {LR: 20041117; JID: 9705947; 0 (Hair Preparations); 0 (Insecticides); 0 (Pyrethrins); 26002-80-2 (phenothrin); 52645-53-1 (Permethrin); ppublish},
	month = {2003},
	pages = {73 - 75},
	address = {Czech Republic},
	abstract = {Pediculosis humanus capitis (head lice) is an important public health problem among school children. In our study, 20,612 schoolchildren (10,367 boys, 10,245 girls) were examined for Pediculus humanus capitis in 36 elementary schools between December 1996 and February 1998 in Ankara, Turkey. The prevalence of pediculosis capitis infestation was found to be 3.4\% (701/20,612). Of these, 382 students were treated with application of 1\% permethrin cream rinse, and 184 students with 0.4\% d-phenothrin shampoo. On day 14 of the controlled trial, the success rates were 93.7\% in the 1\% permethrin cream rinse group and 75.5\% in the 0.4\% d-phenothrin shampoo group. The 1\% permethrin cream rinse was also significantly more active in pediculicidal efficacy when compared to the 0.4\% d-phenothrin shampoo (p<0.001). As a result, these findings demonstrate that pediculosis capitis still remains a widespread health problem.},
	keywords = {animals, child, Comparative Study, hair, humans, insecticide, Lice Infestations/drug therapy/epidemiology, Pediculus, Permethrin, Pyrethrum, scalp dermatoses, Single-Blind Method, Turkey/epidemiology},
	isbn = {1211-4286},
	author = {Tanyuksel,M. and Araz,R. E. and Albay,A. and Aycicek,H.}
}
@article {58,
	title = {Economic considerations associated with Pediculus humanus capitis infestation},
	journal = {Clinical pediatrics},
	volume = {43},
	year = {2004},
	note = {JID: 0372606; 0 (Insecticides); 0 (Pyrethrins); ppublish},
	month = {2004},
	pages = {523 - 527},
	address = {United States},
	abstract = {An estimated 6 to 12 million head lice infestations occur in the United States annually, with children ages 3 to 12 most likely to be affected. There are significant direct costs associated with treatment and indirect costs due to lost time from school. Anecdotal reports suggest that direct costs of treatment are in the hundreds of millions of dollars annually. Indirect costs are also substantial but more difficult to quantify. Examples of indirect costs include missed days from schools that use a "no nit" policy, lost wages for parents who must stay home with children, and costs of daycare for parents who cannot miss work. Contributors to the expense of treating head lice include misdiagnosis, and, consequently unneeded treatment; treatment failure due to misuse of pediculicides or other agents; and developing resistance, particularly to over-the-counter pyrethroid agents. An overview of direct and indirect costs of infestation are included in this review, along with a discussion of factors that lead to misuse and overuse of pediculicides. More accurate diagnosis of head lice infestation may provide the most effective means of controlling the costs of care and ensuring proper use of pediculicides.},
	keywords = {animals, child, Child, Preschool, Cost of Illness, Drug Costs, humans, Infant, insecticide, Lice Infestations/drug therapy/economics, Pediculus, Pyrethrum, Research Support, Non-U.S. Gov{\textquoteright}t, scalp dermatoses, U.S.A.},
	isbn = {0009-9228},
	author = {Hansen,R. C. and O{\textquoteright}Haver,J.}
}
@article {59,
	title = {Efficacy of a reduced application time of Ovide lotion (0.5\% malathion) compared to Nix creme rinse (1\% permethrin) for the treatment of head lice},
	journal = {Pediatric dermatology},
	volume = {21},
	year = {2004},
	note = {JID: 8406799; 0 (Insecticides); 121-75-5 (Malathion); 52645-53-1 (Permethrin); ppublish},
	month = {2004},
	pages = {670 - 674},
	address = {United States},
	abstract = {Our objective was to conduct a randomized, investigator-blinded evaluation of the pediculicidal and ovicidal activity of a reduced application time (20 minutes) of Ovide (0.5\% malathion) compared to Nix (1\% permethrin) in a south Florida population infested with Pediculus humanus capitis. Either Ovide or Nix was applied according to the label instructions. However, Ovide application time was reduced to 20 minutes. At day 8, subjects with live lice were re-treated with the same product and procedure as on day 1. Ovicidal and pediculicidal efficacy were evaluated at days 8 and 15. A subject free of lice and viable eggs at day 15 was considered to be a treatment success. Percent efficacy was calculated using the number of subjects free of lice and viable eggs per total number of subjects treated. We found that a 20-minute application of Ovide was significantly more pediculicidal and ovicidal (98\%) compared to Nix (55\%) at day 15 (p < 0.0001). The percentage of Ovide subjects who required treatment at day 8 was half that of the Nix group. The reinfestation rate was 0\% with Ovide and 33\% with Nix. In conclusion, a 20-minute treatment with Ovide, instead of the approved 8- to 12-hour application, cured 40 of 41 subjects (98\%), demonstrating superior efficacy to Nix. The poor efficacy of Nix confirms the resistance of head lice to permethrin in south Florida.},
	keywords = {adolescent, adult, Aged, animals, child, Comparative Study, Dose-Response, Florida, humans, insecticide, Lice Infestations/drug therapy, malathion, Middle Aged, Pediculus, Permethrin, Research Support, Non-U.S. Gov{\textquoteright}t, scalp dermatoses, Single-Blind Method, Treatment Outcome},
	isbn = {0736-8046},
	author = {Meinking,Terri Lynn and Vicaria,M. and Eyerdam,D. H. and Villar,M. E. and Reyna,S. and Suarez,G.}
}
